Shareholders meeting

Sun Pharmaceutical Industries Limited SUN HOUSE, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 25 August 2026 National Stock Exchange of India Limited BSE Limited Scrip Symbol: SUNPHARMA Scrip Code: 524715 Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Notice of Postal Ballot/E-voting Further to our intimation letters dated 14 May 2026, 22 May 2026, 26 May 2026 and 06 August 2026, this is to inform you that the Notice of the Postal Ballot/E-voting (“Notice”) is being sent to the Members of the Company seeking their approval by way of an Ordinary Resolution for the reclassification of the persons referred to in our intimation dated 14 May 2026 from the ‘Promoter Group’ category to the ‘Public’ category in accordance with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Notice of Postal Ballot is being sent electronically to the Members whose email addresses are registered with the Company/Depositories and whose names appear in the Register of Members/List of Beneficial Owners as on the cut-off date. A copy of the Notice is enclosed herewith and the same is also available on the Company’s website at www.sunpharma.com. The Notice can also be accessed by scanning the QR code. Chronology of Events Receipt of request for reclassification Thursday, 14 May 2026 Review and approval of the Board of Directors Friday, 22 May 2026 Receipt of No-objection Letters from Stock Exchanges Thursday, 06 August 2026 Key dates relating to the Postal Ballot and remote e-voting process Cut-off date for shareholders who are eligible for e-voting Friday, 21 August 2026 E-Voting Begins Friday, 28 August 2026 at 09:00 A.M. E-Voting Ends Saturday, 26 September 2026 at 05.00 P.M. Announcement of Voting Results On or before Tuesday, 29 September 2026 For Sun Pharmaceutical Industries Limited (Anoop Deshpande) Company Secretary and Compliance Officer ICSI Membership No.: A23983 Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA Reaching People. Touching Lives SUN PHARMACEUTICAL INDUSTRIES LIMITED Registered Office: SPARC, Tandalja, Vadodara - 390012, Gujarat, India. Corporate Office: Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (East), Mumbai - 400063, Maharashtra, India. Tel: 022-43244324 CIN: L24230GJ1993PLC019050 | Website: www.sunpharma.com Email: secretarial@sunpharma.com NOTICE OF POSTAL BALLOT / E-VOTING Cut-off Date Voting Opens Voting Closes Results 28 August 2026 26 September 2026 On or before 29 21 August 2026 09:00 A.M. IST 05:00 P.M. IST September 2026 Cut-off Date: Members whose names appear on the Register of Members / List of Beneficial Owners as on the Cut- off Date shall be entitled to vote. Index Sl. No. Section Page No. 1. Executive Summary 2 2. Notice of Postal Ballot / E-voting 3 3. Explanatory Statement 4 a. Background 4 b. Details of the Applicants and Shareholding 4 c. Rationale for Reclassification 4 d. Relationship with Continuing Promoter and Promoter Group 5 e. Pre & Post Reclassification Shareholding 5 f. Board Assessment and Recommendation 5 g. Interest of Directors 6 4. Statutory Notes 7 5. E-voting Guide 8 6. Annexure A – No-objection Letter from BSE 9 7. Annexure B – No-objection Letter from NSE 10 The Notice of the Postal Ballot / E-voting and Explanatory Statement is prepared pursuant to the applicable provisions of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time. Sun Pharmaceutical Industries Limited | Postal Ballot / E-voting Notice | August 2026 Page 1 of 10 Executive Summary [For quick insights on the proposal] The following summary is intended to provide shareholders with a concise overview of the background, rationale and key aspects of the proposed resolution. Shareholders are requested to read the complete explanatory statement before casting their vote. Reclassification of Mr. Sudhir Vrundavandas Valia, Mrs. Raksha Sudhir Valia Resolution proposed and Mrs. Krishna Vrundavandas Valia from “Promoter Group” to “Public” category Resolution Type Ordinary Mode of Voting E-voting (EVSN - 260824035) The Applicants are not involved in the Company’s management or operations Reason for the proposal and do not exercise control or hold special rights, Board representation or KMP positions Collective holding of 4,31,75,371 equity shares, representing 1.80% of the Applicants’ holding Company’s paid-up share capital and voting rights Board approval Approved by the Board on 22 May 2026, subject to requisite approvals Stock Exchange NOCs Received from NSE and BSE on 06 August 2026 Promoter Group holding Will reduce from 54.48% to 52.68% Public holding Will increase from 45.52% to 47.32% Control and management No change in control, management, Board composition or business operations Paid-up share capital No change and no dilution of existing shareholders Other shareholders No impact or change in the rights or economic interests of other shareholders Applicants and persons related to them, as applicable under Regulation 31A, Voting exclusion shall not be entitled to vote to approve the resolution Assessment of the Board of Board has taken note of the declarations received from the Applicants and is of Directors the view that the proposal is not prejudicial to the interests of the shareholders The Board is satisfied, based on the declarations, undertakings and records Compliance Confirmation available with the Company, that the applicable conditions under Regulation 31A have been fulfilled or will continue to be complied with, as applicable Recommendation of the The Board recommends the resolution for shareholders’ approval Board of Directors Sun Pharmaceutical Industries Limited | Postal Ballot / E-voting Notice | August 2026 Page 2 of 10 Notice of Postal Ballot /E-voting [Pursuant to Section 110 and Section 108 of the Companies Act, 2013, read with Rule 20 and 22 of the Companies (Management and Administration) Rules, 2014] NOTICE is hereby given that the resolution as set out below is proposed to be passed by the shareholders of Sun Pharmaceutical Industries Limited (“the Company”) by way of Postal Ballot / E-voting (“Notice”), pursuant to the applicable provisions of the Companies Act, 2013 (“Act”), including the Secretarial Standards and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), as amended from time to time1. This Notice is to be read together with the explanatory statement provided hereunder. Reclassification of Persons from “Promoter Group” category to “Public” category To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Regulation 31A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("SEBI Listing Regulations"), and subject to such other approvals, permissions and sanctions as may be required from the appropriate statutory or regulatory authorities, and pursuant to the No-objection letters dated 06 August 2026 received from BSE Limited and National Stock Exchange of India Limited, consent of the shareholders of the Company be and is hereby accorded for reclassification of Mr. Sudhir Vrundavandas Valia, Mrs. Raksha Sudhir Valia and Mrs. Krishna Vrundavandas Valia, who, as on the date of this Notice, collectively hold 4,31,75,371 equity shares representing 1.80% of the paid- up equity share capital of the Company, from the 'Promoter Group' category to the 'Public' category of shareholders of the Company. RESOLVED FURTHER THAT the Board of Directors of the Company (including any Committee thereof) and the Key Managerial Personnel of the [Showing first 8,000 characters — download PDF for full document]